Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to compare pulmonary function and respiratory muscle strength between children with hearing impairment and their healthy peers. Hearing plays a critical role not only in communication but also in cognitive, sensory, and psychomotor development. Children with hearing impairment may experience balance and coordination problems, vestibular dysfunction, and reduced muscle strength, which may negatively affect respiratory function.
Although several studies have evaluated pulmonary function in children with hearing impairment, research investigating respiratory muscle strength in this population is limited. To our knowledge, no peer-reviewed study has directly compared respiratory muscle strength between children with hearing impairment and healthy controls.
This study will compare spirometric parameters and respiratory muscle strength measurements between children with hearing impairment and age-matched healthy controls.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Children With Hearing Loss | Children aged 7-16 years diagnosed with hearing loss. Participants will undergo pulmonary function testing using spirometry and assessment of respiratory muscle strength (maximum inspiratory pressure [MIP] and maximum expiratory pressure [MEP]). | ||
| Healthy Controls | Age- and sex-matched healthy children aged 7-16 years without hearing impairment. Participants will undergo pulmonary function testing using spirometry and assessment of respiratory muscle strength (maximum inspiratory pressure [MIP] and maximum expiratory pressure [MEP]). |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Maximum Inspiratory Pressure (MIP) | Respiratory muscle strength assessed by measuring maximum inspiratory pressure (cmHâ‚‚O) using a portable electronic mouth pressure device (MicroRPM) according to ATS/ERS guidelines. | At baseline (single assessment) |
| Maximum Expiratory Pressure (MEP) | Forced vital capacity measured by spirometry (COSMED Pony FX) according to ATS/ERS criteria; values expressed as absolute and percentage of predicted values. | At baseline (single assessment) |
| Measure | Description | Time Frame |
|---|---|---|
| Forced Vital Capacity (FVC) | Forced vital capacity measured by spirometry (COSMED Pony FX) according to ATS/ERS criteria; values expressed as absolute and percentage of predicted values. | At baseline (single assessment) |
| Forced Expiratory Volume in 1 Second (FEV1) |
Not provided
Inclusion Criteria For Children With Hearing Loss Group:
For Healthy Control Group:
Exclusion Criteria (Both Groups)
Not provided
Not provided
The study population consists of children aged 7 to 16 years. The hearing loss group includes children diagnosed with hearing impairment who are followed in relevant clinical or educational settings. The control group consists of age- and sex-matched healthy children without hearing impairment. All participants will be screened according to the predefined inclusion and exclusion criteria prior to enrollment.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Deniz Tuncer, PhD, PT | Contact | +90212 401 26 00 | 4647 | dtuncer@bezmialem.edu.tr |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Forced expiratory volume in the first second measured by spirometry; values expressed as absolute and percentage of predicted values. |
| At baseline (single assessment) |
| FEV1/FVC Ratio | Ratio of FEV1 to FVC obtained from spirometric assessment. | At baseline (single assessment) |
| Peak Expiratory Flow (PEF) | Peak expiratory flow measured by spirometry. | At baseline (single assessment) |
| Forced Expiratory Flow 25-75% (FEF25-75%) | Forced expiratory flow between 25% and 75% of FVC measured by spirometry. | At baseline (single assessment) |
| ID | Term |
|---|---|
| D034381 | Hearing Loss |
| ID | Term |
|---|---|
| D006311 | Hearing Disorders |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D012678 | Sensation Disorders |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided